Procter & Gamble Health Limited reported earnings results for the third quarter and nine months ended March 31, 2022. For the third quarter, the company reported sales was INR 2,678.2 million compared to INR 2,191.5 million a year ago. Revenue was INR 2,701.7 million compared to INR 2,223.9 million a year ago. Net income was INR 511.6 million compared to INR 157.7 million a year ago. Basic earnings per share from continuing operations was INR 30.8 compared to INR 9.5 a year ago.
For the nine months, sales was INR 8,185.2 million compared to INR 7,233.4 million a year ago. Revenue was INR 8,286.1 million compared to INR 7,390.2 million a year ago. Net income was INR 1,513.7 million compared to INR 1,429.1 million a year ago. Basic earnings per share from continuing operations was INR 91.2 compared to INR 86.1 a year ago.